EMTROLIF

Welcome to the Brand page for “EMTROLIF”, which is offered here for Antifungal preparations; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for use in dermatology, oncology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, kidney diseases or disorders, and diabetes;.

Its status is currently believed to be active. Its class is unavailable. “EMTROLIF” is believed to be currently owned by “NOVARTIS AG”.